GLP1R and myocardial ischemia: Research found that GLP-1 improves cardiac function, decreases infarct size after myocardial ischemia/reperfusion injury, thus making GLP-1 a promising drug that can be used in dealing with cardiomyocyte injury of diabetic patients (Tao et al., 2018).